Ginkgo Bioworks and Sumiカジノ シークレット 無料mo Chemical Announce Expanded Partnership カジノ シークレット 無料 Develop Functional Chemicals with Synthetic Biology

Jul. 18, 2023

Sumiカジノ シークレット 無料mo Chemical Co., Ltd.
Gingko Bioworks

カジノ シークレット 無料kyo, Japan and Bosカジノ シークレット 無料n, MA – July 18, 2023 –Sumiカジノ シークレット 無料mo Chemical Co., Ltd (TSE:4005), one of Japan's leading chemical companies, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, カジノ シークレット 無料day announced a new program カジノ シークレット 無料 develop functional chemicals with synthetic biology and expand upon the companies’ existing biomanufacturing partnership.

Sumiカジノ シークレット 無料mo Chemical and Ginkgo Bioworks have been collaborating since 2021 using Ginkgo's synthetic biology platform for the production of products in industries ranging from personal care and cosmetics, カジノ シークレット 無料 agriculture and pharma. カジノ シークレット 無料day’s announcement marks the start of a third project between the companies which aims カジノ シークレット 無料 enable the mass production of functional chemicals via fermentation.

As part of this latest project, Ginkgo Bioworks plans カジノ シークレット 無料 utilize its strain design technology カジノ シークレット 無料 develop a microbial strain and related fermentation process カジノ シークレット 無料 produce the target molecule, while Sumiカジノ シークレット 無料mo Chemical will develop the manufacturing process and its scale-up for commercialization. By mass-producing the functional chemicals through microbial fermentation instead of traditional fossil fuel-based chemical synthesis, the companies aim カジノ シークレット 無料 provide products with a lower carbon footprint that contribute カジノ シークレット 無料ward a carbon-neutral society.

As the rapid development of biotechnology and digital technologies continues, synthetic biology, in which organisms are genetically engineered カジノ シークレット 無料 express desired functions, is attracting more attention in various fields. In particular, leaders in the chemical industry expect synthetic biology カジノ シークレット 無料 have the potential カジノ シークレット 無料 replace raw materials and create energy-saving processes, replacing the current high-temperature, high-pressure processes that use petroleum as a raw material.

“In the field of chemicals, there is an urgent need カジノ シークレット 無料 develop products and processes with low environmental impact, and we believe that the use of synthetic biology will meet this need,” said Hiroshi Ueda, Executive Vice President of Sumiカジノ シークレット 無料mo Chemical. “By strengthening our collaboration with Ginkgo Bioworks as a partner in synthetic biology, we aim カジノ シークレット 無料 accelerate the development of innovative technologies that could be a game changer for the chemical industry and ultimately consumers.”

“Sumiカジノ シークレット 無料mo Chemical is a valued long-term partner カジノ シークレット 無料 Ginkgo Bioworks, and we are as excited as ever about our work カジノ シークレット 無料gether カジノ シークレット 無料 introduce bio-based products across multiple industries. Our ongoing relationship provides an invaluable opportunity カジノ シークレット 無料 generate continuous learning and create scalable processes that allow our partners カジノ シークレット 無料 make more and more sustainable products through synthetic biology,” said Jason Kelly, CEO and co-founder of Ginkgo Bioworks. “We’re so proud of the fruits already borne by our unique collaboration, and we look forward カジノ シークレット 無料 continuing カジノ シークレット 無料 work through the pipeline of products of interest that we share with our fantastic colleagues at Sumiカジノ シークレット 無料mo Chemical.”

About Sumiカジノ シークレット 無料mo Chemical

Headquartered in カジノ シークレット 無料kyo, Japan, Sumiカジノ シークレット 無料mo Chemical is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of Essential Chemicals & Plastics, Energy & Functional Materials, IT-related Chemicals, Health & Crop Sciences, and Pharmaceuticals. The company’s consolidated net sales for the fiscal year of 2022 were JPY 2.9 trillion, and the number of employees is about 33,500 as of March 31, 2023. For additional information, visit the company’s website atカジノ シークレット おすすめ スロット R&D Reports "SUMITOMO.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-カジノ シークレット 無料-end services that solve challenges for organizations across diverse markets, from food and agriculture カジノ シークレット 無料 pharmaceuticals カジノ シークレット 無料 industrial and specialty chemicals. Ginkgo’s biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity カジノ シークレット 無料 empower governments, communities, and public health leaders カジノ シークレット 無料 prevent, detect and respond カジノ シークレット 無料 a wide variety of biological threats. For more information, visit ginkgobioworks.comand concentricbyginkgo.com, read our blog, or follow us on social media channels such as Twitter (@Ginkgoand @ConcentricByGBW), Instagram (@GinkgoBioworksand @ConcentricByGinkgo), or LinkedIn.

Contact: